The UV waveband dependencies in mice differ for the suppression of contact hypersensitivity, delayed-type hypersensitivity and cis-urocanic acid formation

被引:25
作者
El-Ghorr, AA [1 ]
Norval, M [1 ]
机构
[1] Univ Edinburgh, Sch Med, Dept Med Microbiol, Edinburgh EH8 9AG, Midlothian, Scotland
关键词
antigen presentation; immunosuppression;
D O I
10.1046/j.1523-1747.1999.00565.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Solar radiation contains ultraviolet B (280-315 nm) and ultraviolet A (ultraviolet All, 315-340 nm; ultraviolet Al, 340-400 nm) wavebands, Ultraviolet B is known to suppress certain aspects of cell mediated immunity. Using three ultraviolet lamps (the broadband ultraviolet B TL-12, the narrow-band ultraviolet B TL-01 and an ultraviolet Al source), we investigated the dose and waveband dependencies for the suppression of contact hypersensitivity to oxazolone and delayed-type hypersensitivity to herpes simplex virus, plus the formation of cis-urocanic acid in C3H/HeN mice. A single exposure of 1500 J/m(2) TL-12 or 10,000 J/m(2) TL-01 or 500,000 J/m(2) ultraviolet Al corresponded to 1 minimum erythema dose in this mouse strain. The percentage of cis-urocanic acid of the total urocanic acid rose from a background level of 1.7% to 40% with 1000 J/m(2) TL-12 or 10,000 J/m(2) TL-01, but only 17% cis-urocanic acid was obtained with 500,000 J/m(2) ultraviolet Al, The contact hypersensitivity response was significantly suppressed after a minimum dose of 5000 J/m(2) TL-12 or 50,000 J/m2 TL-01 or 500,000 J/m2 ultraviolet Al, The delayed-type hypersensitivity response was suppressed by a minimum dose of 100 J/m(2) TL-12 or 10,000 J/m2 TL-01 or 1000 J/m(2) ultraviolet AI, So, whereas a low dose of ultraviolet Al reduced the delayed-type hypersensitivity response, a 500-fold higher dose was required to suppress contact hypersensitivity. There was no correlation between the suppression of these responses and the concentration of cis-urocanic acid in the skin. Thus different mediators may modulate the various immune responses affected by ultraviolet exposure, depending on the wavelength of the radiation.
引用
收藏
页码:757 / 762
页数:6
相关论文
共 33 条
[1]  
BAADSGAARD O, 1990, J IMMUNOL, V145, P2854
[2]   METABOLISM AND FUNCTION OF UROCANIC ACID IN SKIN [J].
BADEN, HP ;
PATHAK, MA .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1967, 48 (01) :11-+
[3]   Chronic low-dose UVA irradiation induces local suppression of contact hypersensitivity, Langerhans cell depletion and suppressor cell activation in C3H/HeJ mice [J].
Bestak, R ;
Halliday, GM .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1996, 64 (06) :969-974
[4]   Mechanisms of indirect allorecognition in graft rejection - Class II MHC allopeptide-specific T cell clones transfer delayed-type hypersensitivity responses in vivo [J].
Chen, WJ ;
Murphy, B ;
Waaga, AM ;
Willett, TA ;
Russell, ME ;
Khoury, SJ ;
Sayegh, MH .
TRANSPLANTATION, 1996, 62 (06) :705-710
[5]  
CHER DJ, 1987, J IMMUNOL, V138, P3688
[6]   COMPARISON OF ACTION SPECTRA FOR ACUTE CUTANEOUS RESPONSES TO ULTRAVIOLET-RADIATION - MAN AND ALBINO HAIRLESS MOUSE [J].
COLE, CA ;
DAVIES, RE ;
FORBES, PD ;
DALOISIO, LC .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1983, 37 (06) :623-631
[7]   DOSE-RESPONSE, WAVELENGTH DEPENDENCE AND RATE OF EXCISION OF ULTRAVIOLET RADIATION-INDUCED PYRIMIDINE DIMERS IN MOUSE SKIN DNA [J].
COOKE, A ;
JOHNSON, BE .
BIOCHIMICA ET BIOPHYSICA ACTA, 1978, 517 (01) :24-30
[8]  
DEGRUIJL FR, 1993, CANCER RES, V53, P53
[9]   THE EFFECT OF CHRONIC LOW-DOSE UVB RADIATION ON LANGERHANS CELLS, SUNBURN CELLS, UROCANIC ACID ISOMERS, CONTACT HYPERSENSITIVITY AND SERUM IMMUNOGLOBULINS IN MICE [J].
ELGHORR, AA ;
NORVAL, M ;
LAPPIN, MB ;
CROSBY, JC .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1995, 62 (02) :326-332
[10]   A MONOCLONAL-ANTIBODY TO CIS-UROCANIC ACID PREVENTS THE ULTRAVIOLET-INDUCED CHANGES IN LANGERHANS CELLS AND DELAYED-HYPERSENSITIVITY RESPONSES IN MICE, ALTHOUGH NOT PREVENTING DENDRITIC CELL ACCUMULATION IN LYMPH-NODES DRAINING THE SITE OF IRRADIATION AND CONTACT HYPERSENSITIVITY RESPONSES [J].
ELGHORR, AA ;
NORVAL, M .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (02) :264-268